Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label,multicentre, single-arm,phase 2 trial |
| |
| Affiliation: | 1. Division of Hematology/Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA;2. Department of Biostatistics, Columbia University Irving Medical Center, New York, NY, USA;3. Department of Radiation Oncology, Columbia University Irving Medical Center, New York, NY, USA;4. Department of Surgery, Columbia University Irving Medical Center, New York, NY, USA;5. Department of Pathology, Columbia University Irving Medical Center, New York, NY, USA;6. Center for Thoracic Cancers, Division of Thoracic Surgery, Massachusetts General Hospital Cancer Center, Boston, MA, USA;7. Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA;8. Lowe Center for Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA;9. Division of Thoracic Surgery, Brigham and Women''s Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA;10. Levine Cancer Institute, Charlotte, NC, USA;11. Tom Baker Cancer Center, Calgary, AB, Canada;12. Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
